MGFA has partnered with Bionews to feature the Myasthenia Gravis News feed on our website, providing the community with research updates, disease management insights, and relevant news. All content is original and produced by Bionews’ editorial staff, and perspectives from patients and caregivers. Information is not meant to replace or provide medical advice.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- Longer-acting experimental MG treatment shows promise in early trialby Steve Bryson, PhD on November 12, 2026 at 3:45 pm
VRDN-008, Viridian Therapeutics’ investigational under-the-skin treatment for myasthenia gravis (MG), sustainably reduces levels of a class of antibodies that includes those driving MG and has the potential for once-every-other-month dosing. That’s according to data from a Phase 1 clinical trial testing the therapy in healthy volunteers. Results also showed that VRDN-008’s half-life, the time it The post Longer-acting experimental MG treatment shows promise in early trial appeared first on Myasthenia Gravis News.
- Living with a chronic illness requires extraordinary effort to appear ordinaryby Sarah Bendiff on November 12, 2026 at 3:00 pm
There are hidden surprises that come with chronic illness, things nobody warns you about and that certainly don’t come with a guidebook. They affect the simplest aspects of our lives, such as looking “normal” — the simple need to fit in, not be singled out, and live like everyone else. Yet sometimes, I feel like The post Living with a chronic illness requires extraordinary effort to appear ordinary appeared first on Myasthenia Gravis News.
- My 2 a.m. battle with prednisone-induced hunger and insomniaby Mark Harrington on November 11, 2026 at 3:00 pm
It’s 2 a.m., and the building is quiet. The only light in my apartment comes from the refrigerator, and I am standing in front of it in my bathrobe, like a man waiting for a bus that isn’t coming. I am not hungry. Let me rephrase that: I ate a perfectly reasonable dinner five hours The post My 2 a.m. battle with prednisone-induced hunger and insomnia appeared first on Myasthenia Gravis News.
- Data from trial of experimental CAR T-cell therapy for gMG due in early 2027by Michela Luciano, PhD on November 10, 2026 at 2:15 pm
Results from a global clinical trial testing the experimental CAR T-cell therapy Descartes-08 in people with generalized myasthenia gravis (gMG) are expected in the first few months of next year, according to its developer, Cartesian Therapeutics. The Phase 3 AURORA trial (NCT06799247), which began enrolling last year, is comparing Descartes-08 with a placebo in up to The post Data from trial of experimental CAR T-cell therapy for gMG due in early 2027 appeared first on Myasthenia Gravis News.
- 3 things I learned that helped me come to terms with my MG diagnosisby Shawna Barnes on November 9, 2026 at 3:00 pm
Receiving a myasthenia gravis (MG) diagnosis can bring a strange mix of emotions. For some people, it’s a relief to finally have an explanation for symptoms that have been disrupting their lives. For others, it feels overwhelming, unfair, or even frightening. Most of us experience all of those feelings at different times. Acceptance doesn’t happen The post 3 things I learned that helped me come to terms with my MG diagnosis appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.






